Docetaxel (Taxotere) in HER-2-positive patients and in combination with trastuzumab (Herceptin).
Year: 2000
Type: article
Source: PubMed
Author: H A Burris
Institution: Sarah Cannon
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2410946992